HIV-1 and HIV-2 dual infection
- 22 January 1998
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 12 (2) , 131-137
- https://doi.org/10.1097/00002030-199802000-00002
Abstract
Objective: We conducted this study to genetically characterize dual infection in individuals demonstrating a dual serological profile. Methods: All subjects were first evaluated by immunoblot for antibody reactivity to the major viral antigens for HIV-1 and HIV-2. Sera were judged to be dual-seropositive if they reacted with strong and equal intensity with the envelope antigens of both HIV-1 and HIV-2 and were confirmed with type-specific recombinant env peptides. We used nested polymerase chain reaction (PCR) to amplify proviral gag and env sequence from peripheral blood mononuclear cell (PBMC) DNA from HIV-1- and HIV-2-infected individuals. Positive amplification was detected after Southern blot hybridization. Results: Plasmid dilution and mixing showed equivalent sensitivity of HIV-1 and HIV-2 primers that was not altered by heterologous target sequences. The DNA PCR showed 100% sensitivity and specificity for detection of monotypic HIV infection. Serologically defined HIV-dual reactives were evaluated by this assay, with 100% detection in female sex workers (21 out of 21), but only 38.5% detection (five out of 13) in hospitalized patients; all being HIV-1 positive only. The lack of HIV-2 proviral signal was significantly correlated with low CD4+ lymphocyte counts (P value = 0.04). Conclusion: The results suggest that HIV dual infection may not be a static condition. Levels of HIV-2 may decrease with disease progression or sequester in tissue reservoirs; our results may also suggest that HIV-1 effectively overgrows HIV-2 in the dually exposed host individual.Keywords
This publication has 25 references indexed in Scilit:
- Natural Protection Against HIV-1 Infection Provided by HIV-2Science, 1995
- Slower heterosexual spread of HIV-2 than HIV-1The Lancet, 1994
- Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reactionAIDS, 1993
- Prevalence and Risk Determinants of Human Immunodeficiency Virus Type 2 (HIV-2) and Human Immunodeficiency Virus Type 1 (HIV-1) in West African Female ProstitutesAmerican Journal of Epidemiology, 1992
- Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'IvoireThe Lancet, 1992
- Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'IvoireThe Lancet, 1992
- Improved Detection of HIV-2 DNA in Clinical Samples Using a Nested Primer-Based Polymerase Chain ReactionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1992
- Fine serotyping of human immunodeficiency virus serotype 1 (HIV-1) and HIV-2 infections by using synthetic oligopeptides representing an immunodominant domain of HIV-1 and HIV-2/simian immunodeficiency virusJournal of Clinical Microbiology, 1991
- Synthetic Peptide Immunoassay Distinguishes HIV Type 1 and HIV Type 2 InfectionsScience, 1987
- A molecular clone of HTLV-III with biological activityNature, 1985